免疫毒素：从设计到临床应用。
Immunotoxins: From Design to Clinical Application.
机构信息
Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Biomolecules. 2021 Nov 15;11(11):1696. doi: 10.3390/biom11111696.
Abstract
The Special Issue of Biomolecules entitled "Immunotoxins, From Design to Clinical Application" contains seven reviews related to immunotoxins [...].
摘要
本期《生物分子》特刊题为“免疫毒素：从设计到临床应用”，包含七篇关于免疫毒素的综述文章[...]。
相似文献
1
Immunotoxins: From Design to Clinical Application.免疫毒素：从设计到临床应用。
Biomolecules. 2021 Nov 15;11(11):1696. doi: 10.3390/biom11111696.
2
Immunotoxins for the treatment of B-cell lymphomas.用于治疗B细胞淋巴瘤的免疫毒素
Mol Med. 1997 Jul;3(7):420-7.
3
Immunotoxins and cancer therapy.免疫毒素与癌症治疗
Cell Mol Immunol. 2005 Apr;2(2):106-12.
4
Rational design of immunotoxins: current progress and future prospects.免疫毒素的合理设计：当前进展与未来展望
Anticancer Drug Des. 1992 Oct;7(5):427-41.
5
Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.化学连接对A链免疫毒素稳定性和细胞毒性活性的影响。
Cancer Treat Res. 1988;37:239-51. doi: 10.1007/978-1-4613-1083-9_14.
6
[Immunotoxins and immunocytokines].[免疫毒素与免疫细胞因子]
Med Sci (Paris). 2019 Dec;35(12):1054-1061. doi: 10.1051/medsci/2019205. Epub 2020 Jan 6.
7
Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy.用于癌症治疗的重组单链和二硫键稳定化Fv免疫毒素
Methods Mol Biol. 2003;207:255-68. doi: 10.1385/1-59259-334-8:255.
8
Therapeutic potential of anti-HIV immunotoxins.抗HIV免疫毒素的治疗潜力。
Antiviral Res. 1996 Dec;33(1):1-9. doi: 10.1016/s0166-3542(96)00995-3.
9
Comparison of immunotoxins bearing a single saporin molecule with multiple toxin conjugates.携带单个皂草毒素分子的免疫毒素与多种毒素偶联物的比较。
Methods Mol Biol. 2001;166:87-100. doi: 10.1385/1-59259-114-0:87.
10
Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications.近年来，铜绿假单胞菌外毒素免疫毒素在癌症治疗应用中的发展和优化。
Int Immunopharmacol. 2021 Jul;96:107759. doi: 10.1016/j.intimp.2021.107759. Epub 2021 May 24.
引用本文的文献
1
Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies.使用CEACAM5特异性纳米抗体在侵袭性前列腺癌中进行快速诊断成像和靶向免疫毒素递送。
J Nanobiotechnology. 2025 Jul 18;23(1):525. doi: 10.1186/s12951-025-03600-x.
2
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from exotoxin A.一种基于源自外毒素A的重组单域抗体免疫毒素的犬B细胞淋巴瘤新疗法。
Front Vet Sci. 2025 Apr 4;12:1491934. doi: 10.3389/fvets.2025.1491934. eCollection 2025.
3
Anthrax: Transmission, Pathogenesis, Prevention and Treatment.炭疽：传播、发病机制、预防与治疗
Toxins (Basel). 2025 Jan 24;17(2):56. doi: 10.3390/toxins17020056.
4
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications.mRNA 药物在临床前和临床应用中的进展和前景。
Signal Transduct Target Ther. 2024 Nov 14;9(1):322. doi: 10.1038/s41392-024-02002-z.
5
Cancer therapy with antibodies.抗体癌症疗法。
Nat Rev Cancer. 2024 Jun;24(6):399-426. doi: 10.1038/s41568-024-00690-x. Epub 2024 May 13.
6
Targeted therapy for multiple myeloma: an overview on CD138-based strategies.多发性骨髓瘤的靶向治疗：基于CD138策略的概述
Front Oncol. 2024 Apr 9;14:1370854. doi: 10.3389/fonc.2024.1370854. eCollection 2024.
7
Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line.神经纤毛蛋白-1 结合肽融合白喉毒素诱导非小细胞肺癌细胞系凋亡。
Curr Pharm Des. 2024;30(17):1317-1325. doi: 10.2174/0113816128292382240325074032.
8
In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.融合尿激酶型纤溶酶原激活物 ATF-TBK 的 Trichobakin 的体内外抗肿瘤作用。
Mol Biol Rep. 2024 Jan 18;51(1):130. doi: 10.1007/s11033-023-09036-6.
9
From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?从免疫毒素到自杀毒素递药方法：是否存在临床机会？
Toxins (Basel). 2022 Aug 23;14(9):579. doi: 10.3390/toxins14090579.
10
Treatment of ovarian cancer with modified anthrax toxin.用改良炭疽毒素治疗卵巢癌。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2210179119. doi: 10.1073/pnas.2210179119. Epub 2022 Aug 2.
本文引用的文献
1
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor.治疗复发难治性多发性骨髓瘤的新方法，重点关注贝兰他单抗莫福汀和塞利尼索的近期获批情况。
Clin Pharmacol. 2021 Aug 18;13:169-180. doi: 10.2147/CPAA.S288840. eCollection 2021.
2
Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation.抗 BCMA 免疫毒素：设计、生产和临床前评估。
Biomolecules. 2020 Sep 29;10(10):1387. doi: 10.3390/biom10101387.
3
Targeting Receptors on Cancer Cells with Protein Toxins.用蛋白毒素靶向癌细胞上的受体。
Biomolecules. 2020 Sep 17;10(9):1331. doi: 10.3390/biom10091331.
4
Development of Recombinant Immunotoxins for Hairy Cell Leukemia.用于毛细胞白血病的重组免疫毒素的研发。
Biomolecules. 2020 Aug 3;10(8):1140. doi: 10.3390/biom10081140.
5
Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors.双特异性靶向表皮生长因子受体和尿激酶受体（uPAR）利用配体靶向毒素在实体瘤。
Biomolecules. 2020 Jun 25;10(6):956. doi: 10.3390/biom10060956.
6
Mechanisms of Resistance to Immunotoxins Containing Exotoxin A in Cancer Therapy.免疫毒素包含细胞毒素 A 用于癌症治疗的耐药机制。
Biomolecules. 2020 Jun 30;10(7):979. doi: 10.3390/biom10070979.
7
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.间皮素靶向免疫毒素LMB-100与抗PD-1抗体在间皮瘤患者及小鼠肿瘤模型中的疗效增强
Sci Transl Med. 2020 Jul 1;12(550). doi: 10.1126/scitranslmed.aaz7252.
8
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors.针对实体瘤的间皮素靶向重组免疫毒素。
Biomolecules. 2020 Jun 28;10(7):973. doi: 10.3390/biom10070973.
9
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update.GPC3 靶向免疫毒素治疗肝癌的研究进展。
Biomolecules. 2020 Jun 20;10(6):934. doi: 10.3390/biom10060934.
10
CCR9 and CCL25: A review of their roles in tumor promotion.CCR9 和 CCL25：在肿瘤促进中的作用综述。
J Cell Physiol. 2020 Dec;235(12):9121-9132. doi: 10.1002/jcp.29782. Epub 2020 May 13.
Zotero 插件